ProBioGen Launches New Website to Enhance User Experience and Streamline Access to Expanded Portfolio
BERLIN, Germany, February 04, 2025 / Biotech Newswire / -- ProBioGen has launched its new, redesigned website to provide biotech and biopharma professionals with clear access to its expanded services and proprietary technologies. The platform delivers an intuitive, user-focused experience and faster access to essential information.
The new website enables visitors to efficiently and more easily explore ProBioGen's comprehensive portfolio, which includes cell line development, cell banking, process and full analytical development, GMP manufacturing, and advanced solutions for proteins, viral vectors, and vaccines. It also spotlights proprietary technologies, such as GlymaxX® and DirectedLuck®, developed to enhance efficacy, boost productivity or accelerate time to clinic.
Key Benefits of the New Website:
- Streamlined navigation: Dedicated sections for CDMO services, technologies, news & resources, and company information makes it faster and easier than ever to find relevant content.
- Comprehensive insights: Detailed descriptions of ProBioGen's portfolio, alongside scientific studies, white papers, or industry updates, provide visitors with the information they need to make informed decisions and advance their projects.
- Enhanced user experience: A fully responsive, interactive design ensures seamless access across all devices, providing convenience to users wherever they are.
"Our relaunched website reflects ProBioGen's commitment to innovation and partnership putting our customers first," said Dr. Gabriele Schneider, Chief Business Officer at ProBioGen. "By focusing on clarity and ease of use, the platform empowers visitors to make faster decisions, plan projects more effectively, and drive innovation in next-generation therapies."
Explore the new website at www.probiogen.de.
